|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
70,540,000 |
Market
Cap: |
N/A |
Last
Volume: |
4,776,453 |
Avg
Vol: |
2,215,743 |
52
Week Range: |
$49.96 - $49.96 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Claypool William D Md |
Director |
|
2012-06-11 |
4 |
S |
$20.04 |
$200,430 |
D/D |
(10,000) |
64,500 |
|
- |
|
Claypool William D Md |
Director |
|
2012-06-11 |
4 |
OE |
$3.42 |
$34,200 |
D/D |
10,000 |
74,500 |
|
- |
|
Pietrusko Robert |
VP, Regulatory & Quality |
|
2012-03-23 |
4 |
AS |
$30.00 |
$600,000 |
D/D |
(20,000) |
4,122 |
|
- |
|
Pietrusko Robert |
VP, Regulatory & Quality |
|
2012-03-23 |
4 |
OE |
$8.86 |
$177,200 |
D/D |
20,000 |
24,122 |
|
- |
|
Fletcher Robert C. |
V.P., Business Development |
|
2012-03-09 |
4 |
S |
$29.65 |
$948,954 |
D/D |
(32,000) |
229 |
|
- |
|
Fletcher Robert C. |
V.P., Business Development |
|
2012-03-09 |
4 |
OE |
$2.09 |
$107,060 |
D/D |
32,000 |
32,229 |
|
- |
|
Rowland Charles A Jr |
VP, Chief Financial Officer |
|
2012-03-07 |
4 |
D |
$29.49 |
$374,965 |
D/D |
(12,715) |
35,048 |
|
- |
|
Rowland Charles A Jr |
VP, Chief Financial Officer |
|
2012-03-07 |
4 |
OE |
$11.96 |
$374,985 |
D/D |
30,638 |
47,763 |
|
- |
|
Doyle Thomas F |
VP Strategic Initiatives |
|
2012-03-05 |
4 |
S |
$32.48 |
$6,820,212 |
D/D |
(210,000) |
52,444 |
|
- |
|
Doyle Thomas F |
VP Strategic Initiatives |
|
2012-03-05 |
4 |
OE |
$2.09 |
$684,700 |
D/D |
210,000 |
262,444 |
|
- |
|
Morris Richard Steven |
Chief Accounting Officer |
|
2012-03-05 |
4 |
S |
$33.01 |
$174,953 |
D/D |
(5,300) |
1,244 |
|
- |
|
Morris Richard Steven |
Chief Accounting Officer |
|
2012-03-05 |
4 |
OE |
$5.91 |
$35,085 |
D/D |
5,300 |
6,544 |
|
- |
|
Soland Daniel B |
VP, Chief Operating Officer |
|
2012-03-01 |
4 |
S |
$32.99 |
$989,700 |
D/D |
(30,000) |
42,881 |
|
- |
|
Rowland Charles A Jr |
VP, Chief Financial Officer |
|
2012-03-01 |
4 |
S |
$32.11 |
$2,657,631 |
D/D |
(82,750) |
17,125 |
|
- |
|
Rowland Charles A Jr |
VP, Chief Financial Officer |
|
2012-03-01 |
4 |
OE |
$5.91 |
$699,200 |
D/D |
70,000 |
99,875 |
|
- |
|
Brooke Paul A |
Director |
|
2012-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
164,500 |
|
- |
|
Leone John R |
Director |
|
2012-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
6,500 |
|
- |
|
Glaser Robert |
Director |
|
2012-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
41,360 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2011-12-23 |
4 |
OE |
$1.84 |
$32,200 |
D/D |
17,500 |
36,939 |
|
- |
|
Baker Felix |
10% Owner |
|
2011-12-14 |
4 |
B |
$27.29 |
$213,613 |
I/I |
7,828 |
303,264 |
1.5 |
- |
|
Baker Julian |
10% Owner |
|
2011-12-14 |
4 |
B |
$27.29 |
$7,960,161 |
I/I |
291,706 |
9,840,469 |
1.5 |
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2011-12-14 |
4 |
AS |
$25.17 |
$1,266,750 |
D/D |
(50,000) |
19,439 |
|
- |
|
Broom Colin Md |
VP & Chief Scientific Officer |
|
2011-12-14 |
4 |
OE |
$8.71 |
$435,500 |
D/D |
50,000 |
44,439 |
|
- |
|
Milano Vincent |
President and CEO |
|
2011-12-05 |
4 |
OE |
$0.99 |
$31,367 |
D/D |
15,005 |
91,213 |
|
- |
|
Doyle Thomas F |
VP Strategic Initiatives |
|
2011-12-01 |
4 |
S |
$23.82 |
$238,159 |
D/D |
(10,000) |
52,444 |
|
- |
|
412 Records found
|
|
Page 5 of 17 |
|
|